Signal Detection and Clarification of Peripheral Neuropathy and Guillain-Barré Syndrome Associated with Exposure to Systemic Fluoroquinolones

Journal Title: Journal of Pharmaceutical Research International - Year 2014, Vol 4, Issue 4

Abstract

Aims: Peripheral neuropathy (PN) is an identified risk of systemic antibacterial therapy with fluoroquinolones. The risk and its severity, including the development of Guillain-Barré syndrome (GBS) between individual agents is uncertain. This study examines the association between fluoroquinolones and PN and GBS in cases spontaneously reported to the FDA Adverse Event Reporting System (FAERS). Study Design: Retrospective pharmacovigilance analysis. Place and Duration of Study: Cases submitted to FAERS between 1997 and 2012. Methodology: The MedDRA Preferred Term was used to define PN and GBS. Individual fluoroquinolones were identified by generic names and route of administration. Empirical Bayes Geometric Mean (EBGM) with 95% confidence interval (EB05-EB95) was calculated as disproportionality measure. Safety signals with EB05>2 was considered a significant disproportional increase in event reporting of at least twice times higher than expected. Results: There were 539 PN reports out of 46,257 adverse event reports submitted for fluoroquinolones. 9% of PN reports were for GBS. Significant disproportionality of PN (EBGM 2.70; EB05-EB95 2.51-2.90) and GBS (EBGM 3.22; EB05-EB95 2.55-4.02) was identified for fluoroquinolones. Signals of PN were detected for ciprofloxacin (EBGM 3.24; EB05-EB95 2.87-3.66) and levofloxacin (EBGM 3.36; EB05-EB95 3.02-3.72). A GBS signal was detected for ciprofloxacin (EBGM 4.15; EB05-EB95 2.94-5.74). GBS and PN respectively ranked 6th and 8th among reported neurological events. Conclusion: This study reemphasizes the link between fluoroquinolones and PN, and shows potential association with more severe forms of nerve damage, e.g. GBS. Unless the benefit of fluoroquinolone therapy outweighs PN risk, treatment with alternative antibacterial agents is recommended.

Authors and Affiliations

Ayad K. Ali

Keywords

Related Articles

Physicochemical and Bioequivalence Studies on Some Brands of Levofloxacin Tablets Registered in Nigeria

Aims: This study was aimed at comparing the physicochemical and bioavailability profiles of some brands of Levofloxacin 500mg tablets that are registered in Nigeria by her regulatory authority and to examine the feasibil...

Biosynthesis of Silver Nanoparticles Using Callus Extract of Catharanthus roseus var. alba and Assessment of Its Antimicrobial Activity

Objective: To express a cost efficacious and environment friendly method for the green synthesis of silver nanoparticles (AgNPs) from Catharanthus roseus var. alba (C. roseus var. alba) callus extract. Methodology: The...

Anti-proliferative Effect of Isoflavones Isolated from Soybean and Soymilk Powder on Lymphoma (DG 75) and Leukemia (CEM) Cell Lines

Aim: Isoflavones in soybean have been linked to reduced risk of some cardiovascular diseases as well as some type of cancers. Extensive epidemiological, in-vitro and animal data suggests lower incidence of cardiovascular...

Investigation of Nano Lipid Vesicles of Lornoxicam for Targeted Drug Delivery

Aim: The aim of the present study was to formulate nano lipid vesicles of lornoxicam targeting to the specific site (inflamed area), and investigating it’s in vivo anti-inflammatory activity in animals (rats). Methods: L...

Antiangiogenic and Apoptotic Effects of Oleuropein on Breast Cancer Cells

Oleuropein is a fundamental polyphenol contained in olive fruit, oil, and leaf, with a bitter taste. A decrease in its level is observed as the fruit ripens. Leaves of oil tree were used in this study as a possible origi...

Download PDF file
  • EP ID EP344673
  • DOI 10.9734/BJPR/2014/6954
  • Views 77
  • Downloads 0

How To Cite

Ayad K. Ali (2014). Signal Detection and Clarification of Peripheral Neuropathy and Guillain-Barré Syndrome Associated with Exposure to Systemic Fluoroquinolones. Journal of Pharmaceutical Research International, 4(4), 407-417. https://europub.co.uk./articles/-A-344673